跳至主要内容
临床试验/ACTRN12616001248459
ACTRN12616001248459已完成1 期

A pharmacokinetic study of metformin in patients with stable stage 4 chronic kidney disease and type 2 diabetes

Dr Ajith Dissanayake0 个研究点目标入组 18 人开始时间: 2016年9月7日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
30 Years 至 75 Years(—)
性别
All

入选标准

  • 1. Type 2 diabetes for at least 2 years
  • 2. Haemoglobin A1c between 6 and 11%
  • 3. Stable stage 4 chronic kidney disease as defined by estimated glomerular filtration rate of 15-29mls/1.73m2.

排除标准

  • 1. Current treatment with metformin
  • 2. Previous intolerance to metformin
  • 3. Body mass greater than 160kg
  • 4. Severe COPD as evidenced by hospitalization for decompensation within 6 months of randomization, chronic treatment with oral steroids
  • 5. Unstable CHF needing frequent hospitalisations or frequent adjustment of heart failure medications
  • 6. Significant IHD with acute coronary event, and/or CABG, and/or PCI in the previous 60 days.
  • 7. Severe liver disease with icterus and plasma bilirubin greater than or equal to 60 micrommol/L, plasma transaminase greater than 3-fold upper limit of normal, albumin less than 25 g/L or coagulopathy.
  • 8. Haemoglobin less tha 100 g/L or platelet count less than 80,000/mm3
  • 9. Gastrointestinal bleeding in the previous 60 days
  • 10. Unstable angina or planned for invasive cardiac investigations in the next 6 months
  • 11. Malignancy other than basal cell carcinoma.
  • 12. Any other disease or condition which in the opinion of the investigator could make them unsuitable for entry.
  • 13. Pregnant, nursing a child, or planning a pregnancy at the time of this study

研究者

发起方
Dr Ajith Dissanayake

相似试验